This report aims to provide a comprehensive presentation of the global market for Oncology Drugs, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Drugs.
The Oncology Drugs market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oncology Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Drugs manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
The global Oncology Drugs market size in 2022 is 156700.00 million US dollars, and it is expected to be 256606.14 million US dollars by 2029, with a compound annual growth rate of 7.30% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Oncology Drugs market include Abbvie Inc., Amgen, Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, and Johnson & Johnson Services, Inc.. The share of the top 3 players in the Oncology Drugs market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of Oncology Drugs market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Oral accounted for XX% of Oncology Drugs market in 2022. Parenteral share of XX%.
Hospitals accounted for XX% of the Oncology Drugs market in 2022. Clinics accounts for XX%.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Oncology Drugs market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the Oncology Drugs industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and the latest developments.
Chapters 4-5: Segmented the global Oncology Drugs market by type, and application. Analyze the revenue, sales and price of market segments from different perspectives.
Chapters 6-7: Provide global Oncology Drugs market production status and consumption status by region.
Chapters 8-12: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Oncology Drugs market country segmentation data.
Chapter 13: Analyzes the Oncology Drugs industry chain, including raw material analysis, sales and marketing, distributors and major downstream buyers.
Chapter 14: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes market technology analysis.
Chapter 15: The main points and conclusions of the report.
Chapter 16: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Player list
Abbvie Inc.
Amgen, Inc.
AstraZeneca PLC
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Novartis AG
Others
Types list
Oral
Parenteral
Others
Application list
Hospitals
Clinics
Specialty Centers
Research Institutes
Others
Table of Content
1 Study Coverage
1.1 Oncology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Study Objectives
1.5 Years Considered
1.6 Currency Exchange Rate
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Oncology Drugs Sales by Players
2.1.1 Global Oncology Drugs Sales by Players (2018-2023)
2.1.2 Global Oncology Drugs Sales Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Largest Players of Oncology Drugs in 2023
2.2 Global Oncology Drugs Revenue by Players
2.2.1 Global Oncology Drugs Revenue by Players (2018-2023)
2.2.2 Global Oncology Drugs Revenue Market Share by Players (2018-2023)
2.2.3 Global Top 5 and Top 10 Companies by Oncology Drugs Revenue in 2023
2.3 Global Oncology Drugs Sales Price by Players
2.4 Analysis of Competitive Landscape
2.4.1 Players Market Concentration Ratio (CR5)
2.4.2 Global Oncology Drugs Players Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Abbvie Inc.
3.1.1 Abbvie Inc. Information
3.1.2 Abbvie Inc. Overview
3.1.3 Abbvie Inc. Oncology Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
3.1.4 Abbvie Inc. Related Developments
3.2 Amgen, Inc.
3.2.1 Amgen, Inc. Information
3.2.2 Amgen, Inc. Overview
3.2.3 Amgen, Inc. Oncology Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
3.2.4 Amgen, Inc. Related Developments
3.3 AstraZeneca PLC
3.3.1 AstraZeneca PLC Information
3.3.2 AstraZeneca PLC Overview
3.3.3 AstraZeneca PLC Oncology Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
3.3.4 AstraZeneca PLC Related Developments
3.4 F. Hoffmann-La Roche Ltd
3.4.1 F. Hoffmann-La Roche Ltd Information
3.4.2 F. Hoffmann-La Roche Ltd Overview
3.4.3 F. Hoffmann-La Roche Ltd Oncology Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
3.4.4 F. Hoffmann-La Roche Ltd Related Developments
3.5 Johnson & Johnson Services, Inc.
3.5.1 Johnson & Johnson Services, Inc. Information
3.5.2 Johnson & Johnson Services, Inc. Overview
3.5.3 Johnson & Johnson Services, Inc. Oncology Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
3.5.4 Johnson & Johnson Services, Inc. Related Developments
3.6 Merck & Co., Inc.
3.6.1 Merck & Co., Inc. Information
3.6.2 Merck & Co., Inc. Overview
3.6.3 Merck & Co., Inc. Oncology Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
3.6.4 Merck & Co., Inc. Related Developments
3.7 Novartis AG
3.7.1 Novartis AG Information
3.7.2 Novartis AG Overview
3.7.3 Novartis AG Oncology Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
3.7.4 Novartis AG Related Developments
3.8 Others
3.8.1 Others Information
3.8.2 Others Overview
3.8.3 Others Oncology Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
3.8.4 Others Related Developments
4 Market Size by Type
4.1 Global Oncology Drugs Sales by Type
4.1.1 Global Oncology Drugs Sales by Type (2018-2023)
4.1.2 Global Oncology Drugs Forecasted Sales by Type (2023-2029)
4.2 Global Oncology Drugs Revenue by Type
4.2.1 Global Oncology Drugs Revenue by Type (2018-2023)
4.2.2 Global Oncology Drugs Forecasted Revenue by Type (2023-2029)
4.3 Global Oncology Drugs Price by Type
4.3.1 Global Oncology Drugs Price by Type (2018-2023)
4.3.2 Global Oncology Drugs Price Forecast by Type (2023-2029)
5 Market Size by Application
5.1 Global Oncology Drugs Sales by Application
5.1.1 Global Oncology Drugs Sales by Application (2018-2023)
5.1.2 Global Oncology Drugs Forecasted Sales by Application (2023-2029)
5.2 Global Oncology Drugs Revenue by Application
5.2.1 Global Oncology Drugs Revenue by Application (2018-2023)
5.2.2 Global Oncology Drugs Forecasted Revenue by Application (2023-2029)
5.3 Global Oncology Drugs Price by Application
5.3.1 Global Oncology Drugs Price by Application (2018-2023)
5.3.2 Global Oncology Drugs Price Forecast by Application (2023-2029)
6 Global Oncology Drugs Production
6.1 Global Oncology Drugs Production (2018-2029)
6.2 Global Oncology Drugs Production by Region: 2018 VS 2023 VS 2029
6.3 Global Oncology Drugs Production by Region
6.3.1 Global Oncology Drugs Historic Production by Region (2018-2023)
6.3.2 Global Oncology Drugs Forecasted Production by Region (2023-2029)
6.4 North America
6.5 Europe
6.6 China
6.7 Japan
7 Global Oncology Drugs Market Insights Estimates and Forecasts
7.1 Global Oncology Drugs Sales Estimates and Forecasts 2018-2029
7.2 Global Oncology Drugs Revenue Estimates and Forecasts 2018-2029
7.3 Global Oncology Drugs Sales by Region: 2018 VS 2023 VS 2029
7.4 Global Oncology Drugs Sales by Region
7.4.1 Global Oncology Drugs Sales by Region (2018-2023)
7.4.2 Global Oncology Drugs Sales by Region (2023-2029)
7.5 Global Oncology Drugs Revenue by Region
7.5.1 Global Oncology Drugs Revenue by Region (2018-2023)
7.5.2 Global Oncology Drugs Revenue by Region (2023-2029)
7.6 North America
7.7 Europe
7.8 Asia-Pacific
7.9 Latin America
7.10 Middle East & Africa
8 North America
8.1 North America Oncology Drugs Market Size by Country
8.1.1 North America Oncology Drugs Sales by Country (2018-2029)
8.1.2 North America Oncology Drugs Revenue by Country (2018-2029)
8.1.3 U.S.
8.1.4 Canada
9 Europe
9.1 Europe Oncology Drugs Market Size by Country
9.1.1 Europe Oncology Drugs Sales by Country (2018-2029)
9.1.2 Europe Oncology Drugs Revenue by Country (2018-2029)
9.1.3 Germany
9.1.4 France
9.1.5 U.K.
9.1.6 Italy
9.1.7 Russia
10 Asia Pacific
10.1 Asia Pacific Oncology Drugs Market Size by Region
10.1.1 Asia Pacific Oncology Drugs Sales by Region (2018-2029)
10.1.2 Asia Pacific Oncology Drugs Revenue by Region (2018-2029)
10.1.3 China
10.1.4 Japan
10.1.5 South Korea
10.1.6 India
10.1.7 Southeast Asia
10.1.8 Australia
11 Latin America
11.1 Latin America Oncology Drugs Market Size by Country
11.1.1 Latin America Oncology Drugs Sales by Country (2018-2029)
11.1.2 Latin America Oncology Drugs Revenue by Country (2018-2029)
11.1.3 Mexico
11.1.4 Brazil
12 Middle East and Africa
12.1 Middle East and Africa Oncology Drugs Market Size by Country
12.1.1 Middle East and Africa Oncology Drugs Sales by Country (2018-2029)
12.1.2 Middle East and Africa Oncology Drugs Revenue by Country (2018-2029)
12.1.3 Turkey
12.1.4 Saudi Arabia
12.1.5 U.A.E
13 Value Chain and Channels Analysis
13.1 Oncology Drugs Value Chain Analysis
13.2 Oncology Drugs Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Oncology Drugs Production Mode & Process
13.4 Oncology Drugs Sales and Marketing
13.4.1 Oncology Drugs Sales Channels
13.4.2 Oncology Drugs Distributors
13.5 Oncology Drugs Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Oncology Drugs Industry Trends
14.2 Oncology Drugs Market Drivers
14.3 Oncology Drugs Market Challenges
14.4 Oncology Drugs Market Restraints
14.5 Oncology Drugs Market Technology Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer
List of Tables and Figures
Figure Oncology Drugs Picture
Table Product Definition of Oncology Drugs
Table Global Oncology Drugs Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
Table Global Oncology Drugs Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Oncology Drugs Sales by Players (2018-2023)
Table Global Oncology Drugs Sales Market Share by Players (2018-2023)
Figure Top 5 Largest Players of Oncology Drugs in 2023
Figure Top 10 Largest Players of Oncology Drugs in 2023
Table Global Oncology Drugs Revenue by Players (2018-2023)
Table Global Oncology Drugs Revenue Market Share by Players (2018-2023)
Figure Top 5 Largest Players of Oncology Drugs in 2023
Figure Top 10 Largest Players of Oncology Drugs in 2023
Table Global Oncology Drugs Sales Price by Players
Table Players Market Concentration Ratio (CR5)
Table Global Oncology Drugs Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Abbvie Inc. Overview
Table Abbvie Inc. Sales, Price, Revenue, Gross, Gross Margin 2018-2023
Table Abbvie Inc. Related Developments
Table Company Profiles
Table Amgen, Inc. Overview
Table Amgen, Inc. Sales, Price, Revenue, Gross, Gross Margin 2018-2023
Table Amgen, Inc. Related Developments
Table Company Profiles
Table AstraZeneca PLC Overview
Table AstraZeneca PLC Sales, Price, Revenue, Gross, Gross Margin 2018-2023
Table AstraZeneca PLC Related Developments
Table Company Profiles
Table F. Hoffmann-La Roche Ltd Overview
Table F. Hoffmann-La Roche Ltd Sales, Price, Revenue, Gross, Gross Margin 2018-2023
Table F. Hoffmann-La Roche Ltd Related Developments
Table Company Profiles
Table Johnson & Johnson Services, Inc. Overview
Table Johnson & Johnson Services, Inc. Sales, Price, Revenue, Gross, Gross Margin 2018-2023
Table Johnson & Johnson Services, Inc. Related Developments
Table Company Profiles
Table Merck & Co., Inc. Overview
Table Merck & Co., Inc. Sales, Price, Revenue, Gross, Gross Margin 2018-2023
Table Merck & Co., Inc. Related Developments
Table Company Profiles
Table Novartis AG Overview
Table Novartis AG Sales, Price, Revenue, Gross, Gross Margin 2018-2023
Table Novartis AG Related Developments
Table Company Profiles
Table Others Overview
Table Others Sales, Price, Revenue, Gross, Gross Margin 2018-2023
Table Others Related Developments
Table Global Oncology Drugs Sales by Type (2018-2023)
Table Global Oncology Drugs Sales Share by Type (2018-2023)
Table Global Oncology Drugs Forecasted Sales by Type (2023-2029)
Table Global Oncology Drugs Forecasted Sales Share by Type (2023-2029)
Table Global Oncology Drugs Revenue by Type (2018-2023)
Table Global Oncology Drugs Revenue Share by Type (2018-2023)
Table Global Oncology Drugs Forecasted Revenue by Type (2023-2029)
Table Global Oncology Drugs Forecasted Revenue Share by Type (2023-2029)
Table Global Oncology Drugs Price by Type (2018-2023)
Table Global Oncology Drugs Price Forecast by Type (2023-2029)
Table Global Oncology Drugs Sales by Application (2018-2023)
Table Global Oncology Drugs Sales Share by Application (2018-2023)
Table Global Oncology Drugs Forecasted Sales by Application (2023-2029)
Table Global Oncology Drugs Forecasted Sales Share by Application (2023-2029)
Table Global Oncology Drugs Revenue by Application (2018-2023)
Table Global Oncology Drugs Revenue Share by Application (2018-2023)
Table Global Oncology Drugs Forecasted Revenue by Application (2023-2029)
Table Global Oncology Drugs Forecasted Revenue Share by Application (2023-2029)
Table Global Oncology Drugs Price by Application (2018-2023)
Table Global Oncology Drugs Price Forecast by Application (2023-2029)
Figure Global Oncology Drugs Production (2018-2029)
Table Global Oncology Drugs Production by Region: 2018 VS 2023 VS 2029
Table Global Oncology Drugs Historic Production by Region (2018-2023)
Table Global Oncology Drugs Historic Production Share by Region (2018-2023)
Table Global Oncology Drugs Forecasted Production by Region (2023-2029)
Table Global Oncology Drugs Forecasted Production Share by Region (2023-2029)
Figure North America Oncology Drugs Production (2018-2029)
Figure Europe Oncology Drugs Production (2018-2029)
Figure China Oncology Drugs Production (2018-2029)
Figure Japan Oncology Drugs Production (2018-2029)
Figure Global Oncology Drugs Sales Estimates and Forecasts 2018-2029
Figure Global Oncology Drugs Revenue Estimates and Forecasts 2018-2029
Table Global Oncology Drugs Sales by Region: 2018 VS 2023 VS 2029
Table Global Oncology Drugs Sales by Region (2018-2023)
Table Global Oncology Drugs Sales Share by Region (2018-2023)
Table Global Oncology Drugs Sales by Region (2023-2029)
Table Global Oncology Drugs Sales Share by Region (2023-2029)
Table Global Oncology Drugs Revenue by Region (2018-2023)
Table Global Oncology Drugs Revenue Share by Region (2018-2023)
Table Global Oncology Drugs Revenue by Region (2023-2029)
Table Global Oncology Drugs Revenue Share by Region (2023-2029)
Figure North America Oncology Drugs Sales (2018-2029)
Figure North America Oncology Drugs Revenue (2018-2029)
Figure Europe Oncology Drugs Sales (2018-2029)
Figure Europe Oncology Drugs Revenue (2018-2029)
Figure Asia-Pacific Oncology Drugs Sales (2018-2029)
Figure Asia-Pacific Oncology Drugs Revenue (2018-2029)
Figure Latin America Oncology Drugs Sales (2018-2029)
Figure Latin America Oncology Drugs Revenue (2018-2029)
Figure Middle East & Africa Oncology Drugs Sales (2018-2029)
Figure Middle East & Africa Oncology Drugs Revenue (2018-2029)
Table North America Oncology Drugs Sales by Country (2018-2029)
Table North America Oncology Drugs Sales Share by Country (2018-2029)
Table North America Oncology Drugs Revenue by Country (2018-2029)
Table North America Oncology Drugs Revenue Share by Country (2018-2029)
Figure United States Oncology Drugs Sales Market Size (2018-2029)
Figure United States Oncology Drugs Revenue Market Size (2018-2029)
Figure Canada Oncology Drugs Sales Market Size (2018-2029)
Figure Canada Oncology Drugs Revenue Market Size (2018-2029)
Table Europe Oncology Drugs Sales by Country (2018-2029)
Table Europe Oncology Drugs Sales Share by Country (2018-2029)
Table Europe Oncology Drugs Revenue by Country (2018-2029)
Table Europe Oncology Drugs Revenue Share by Country (2018-2029)
Figure Germany Oncology Drugs Sales Market Size (2018-2029)
Figure Germany Oncology Drugs Revenue Market Size (2018-2029)
Figure France Oncology Drugs Sales Market Size (2018-2029)
Figure France Oncology Drugs Revenue Market Size (2018-2029)
Figure U.K. Oncology Drugs Sales Market Size (2018-2029)
Figure U.K. Oncology Drugs Revenue Market Size (2018-2029)
Figure Italy Oncology Drugs Sales Market Size (2018-2029)
Figure Italy Oncology Drugs Revenue Market Size (2018-2029)
Figure Russia Oncology Drugs Sales Market Size (2018-2029)
Figure Russia Oncology Drugs Revenue Market Size (2018-2029)
Table Asia Pacific Oncology Drugs Sales by Region (2018-2029)
Table Asia Pacific Oncology Drugs Sales Share by Region (2018-2029)
Table Asia Pacific Oncology Drugs Revenue by Region (2018-2029)
Table Asia Pacific Oncology Drugs Revenue Share by Region (2018-2029)
Figure China Oncology Drugs Sales Market Size (2018-2029)
Figure China Oncology Drugs Revenue Market Size (2018-2029)
Figure Japan Oncology Drugs Sales Market Size (2018-2029)
Figure Japan Oncology Drugs Revenue Market Size (2018-2029)
Figure South Korea Oncology Drugs Sales Market Size (2018-2029)
Figure South Korea Oncology Drugs Revenue Market Size (2018-2029)
Figure India Oncology Drugs Sales Market Size (2018-2029)
Figure India Oncology Drugs Revenue Market Size (2018-2029)
Figure Southeast Asia Oncology Drugs Sales Market Size (2018-2029)
Figure Southeast Asia Oncology Drugs Revenue Market Size (2018-2029)
Figure Australia Oncology Drugs Sales Market Size (2018-2029)
Figure Australia Oncology Drugs Revenue Market Size (2018-2029)
Table Latin America Oncology Drugs Sales by Country (2018-2029)
Table Latin America Oncology Drugs Sales Share by Country (2018-2029)
Table Latin America Oncology Drugs Revenue by Country (2018-2029)
Table Latin America Oncology Drugs Revenue Share by Country (2018-2029)
Figure Mexico Oncology Drugs Sales Market Size (2018-2029)
Figure Mexico Oncology Drugs Revenue Market Size (2018-2029)
Figure Brazil Oncology Drugs Sales Market Size (2018-2029)
Figure Brazil Oncology Drugs Revenue Market Size (2018-2029)
Table Middle East and Africa Oncology Drugs Sales by Country (2018-2029)
Table Middle East and Africa Oncology Drugs Sales Share by Country (2018-2029)
Table Middle East and Africa Oncology Drugs Revenue by Country (2018-2029)
Table Middle East and Africa Oncology Drugs Revenue Share by Country (2018-2029)
Figure Turkey Oncology Drugs Sales Market Size (2018-2029)
Figure Turkey Oncology Drugs Revenue Market Size (2018-2029)
Figure Saudi Arabia Oncology Drugs Sales Market Size (2018-2029)
Figure Saudi Arabia Oncology Drugs Revenue Market Size (2018-2029)
Figure U.A.E Oncology Drugs Sales Market Size (2018-2029)
Figure U.A.E Oncology Drugs Revenue Market Size (2018-2029)
Table Raw Material
Table Raw Materials Key Suppliers
Figure Sales Channels
Table Major Distributors of Oncology Drugs with Contact Information
Table Major Customers of Oncology Drugs with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report